The BoD is in discussions with the Royal Statistical Society about a possible union.
While the discussions are at an early stage, the BoD believes that a merger could put extra resources behind PSI’s activities leading to greater reach for pharmaceutical statisticians. At this point, the union team would like to share with the membership the pros and cons that have been debated at the BoD and to to solicit feedback on our plans.
No votes or decisions will be taken at this meeting – the objective is to get a feel for the views of the membership to best inform our evaluation of the options in front of PSI.
PSI, the European Federation of Statisticians in the Pharmaceutical Industry (EFSPI) and the Biopharmaceutical Section of the American Statistical Association (ASA) are jointly organising a webinar on Estimands in Practice. Speakers from regulatory authorities (FDA and EMA) and industry will present on their experience on this topic to date.
Discover your potential by working as a Covance Senior Principal / Principal Biostatistician. You'll enjoy a varied role working for different sponsors across several therapeutic areas, leading projects and mentoring junior members of the department.
Biometrics at AstraZeneca provides the data that influences decisions on how we roll back the frontiers of science to bring life-changing medicines to the world. We are at the heart of design, analytics and interpretation of AstraZeneca’s portfolio.